FASCINATION ABOUT AI IN CELL AND GENE THERAPY MARKET BY TECHNOLOGY, BY INDICATION, BY APPLICATION, BY END-USER (BIOPHARMACEUTICAL COMPANIES, RESEARCH INSTITUTES, HEALTHCARE PROVIDERS) AND BY REGION

Europe AI in healthcare market is anticipated to witness sizeable development. This may be attributed for the popular adoption of AI technologies and escalating investments in AI by equally federal government and personal organizations. Gene- and RNA-dependent therapies, Conversely, are unlikely to Enjoy a major role during the brief to medium exp